Table of Content - Asthma And COPD Market

Asthma is a condition in which a patient’s airways narrow and swell and may produce extra mucus. This can make breathing difficult and trigger coughing, a whistling sound (wheezing) when a patient breathes out and shortness of breath. For some people, asthma is a minor nuisance, for others, it can be a major problem that interferes with daily activities and may lead to a life-threatening asthma attack. Asthma cannot be cured, but its symptoms can be controlled. Because asthma often changes over time, it's important that a patient works with doctors to track the signs and symptoms and adjust your treatment as needed. COPD is a chronic inflammatory lung disease, in which airways become blocked, leading to wheezing and shortness of breath.

Market Dynamics

The launch of new products is attributed to the growth of the global asthma and COPD market. For instance, in June 2021, GLENMARK PHARMACEUTICALS LTD, a research-based, global pharmaceutical company, launched Tiogiva, a tiotropium bromide dry powder inhaler (DPI) for the treatment of chronic obstructive pulmonary disease (COPD), in the U.K. Tiogiva’s active ingredient, tiotropium bromide, is a bronchodilator— an agent that relaxes airway muscles so they can widen. Due to its bronchodilator properties, tiotropium can ease several COPD symptoms, including shortness of breath, wheezing, coughing, and chest tightness.

Key features of the study:

This report provides an in-depth analysis of the global asthma and COPD market and provides market size (US$ Bn) and compound annual growth rate (CAGR) for the forecast period (2023–2030), considering 2022 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global asthma and COPD market based on the following parameters– company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include AstraZeneca, Novartis AG, GSP plc, Merck & Co., Inc., Verona Pharma plc, Regeneron Pharmaceuticals Inc., and Boehringer Ingelheim International GmbH
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding its future product launches, type up-gradation, market expansion, and marketing tactics
Global asthma and COPD market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global asthma and COPD market.

Detailed Segmentation:

Global Asthma And COPD Market, By Drug Type:
- By Drug Type
  - Bronchodilators
    - Short Acting Bronchodilators
    - Long Acting Bronchodilators
  - Anti-Inflammatories
    - Inhaled Corticosteroids
    - Leukotriene Modulators
    - Others
- Combined Therapies
Global Asthma And COPD Market, By Disease type:
- By Disease Type
  - Asthma
  - COPD
Global Asthma And COPD Market, By Dsitribution Channel:
- Hospital Pharmacies
- Retail Pharemacies
- Online Pharmacies
Global Asthma And COPD Market, By Region:
- North America
  - U.S.
  - Canada
- Latin America
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
- Europe
  - Germany
  - U.K.
  - France
  - Italy
  - Spain
  - Russia
  - Rest of Europe
- Asia Pacific
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
- Middle East
  - GCC
  - Israel
  - Rest of Middle East
- Africa
  - South Africa
  - Central Africa
  - North Africa
Company Profiles
- AstraZeneca
- Novartis AG
- GSP plc,
- Merck & Co., Inc.
- Verona Pharma plc
- Regeneron Pharmaceuticals Inc.
- Boehringer Ingelheim International GmbH.

Table of Contents

Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
Market Purview
- Report Description
  - Market Definition and Scope
- Executive Summary
  - Market Snapshot, By Drug Type
  - Market Snapshot, By Disease Type
  - Market Snapshot, By Distribution Channel
  - Market Snapshot, By Region
- Coherent Opportunity Map (COM)
Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
  - Drivers
  - Restraints
  - Market Opportunities
- Impact Analysis
- Recent Product Launches
- Epidemiology
- Merger, Acquisition, and Collaborations
- Regulatory Scenario
- Key Developments
- PEST Analysis
Global Asthma And COPD Market– COVID-19 Impact Analysis
- Economic Impact
- COVID-19 Epidemiology
- Impact on Supply and Demand
Global Asthma And COPD Market, By Drug Type, 2018–2030, (US$ Bn)
- Introduction
  - Market Share Analysis, 2023 and 2030 (%)
  - Y-o-Y Growth Analysis, 2018–2030
  - Segment Trends
- Bronchodilators
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2018–2030, (US$ Bn)
  - Short Acting Bronchodilators
  - Long Acting Bronchodilators
- Anti-Inflammatories
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2018–2030, (US$ Bn)
  - Inhaled Corticosteroids
  - Leukotriene Modulators
  - Others
- Combination Therapies
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2018–2030, (US$ Bn)
Global Asthma And COPD Market, By Disease Type, 2018–2030, (US$ Bn)
- Introduction
  - Market Share Analysis, 2023 and 2030 (%)
  - Y-o-Y Growth Analysis, 2018–2030
  - Segment Trends
- Asthma
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2018–2030, (US$ Bn)
- COPD
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2018–2030, (US$ Bn)
Global Asthma And COPD Market, By Distribution Channel, 2018–2030, (US$ Bn)
- Introduction
  - Market Share Analysis, 2023 and 2030 (%)
  - Y-o-Y Growth Analysis, 2018–2030
  - Segment Trends
- Hospital Pharmacies
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2018–2030, (US$ Bn)
- Retail Pharmacies
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2018–2030, (US$ Bn)
- Online Pharmacies
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2018–2030, (US$ Bn)
Global Asthma And COPD Market, By Region, 2018–2030, (US$ Bn)
- Introduction
  - Market Share Analysis, By Region, 2023 and 2030 (%)
  - Y-o-Y Growth Analysis, For Regions, 2018–2030
  - Regional Trends
- North America
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Drug type, 2018-2030, (US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2018-2030, (US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2018–2030, (US$ Bn)
    - U.S.
    - Canada
- Latin America
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Drug type, 2018-2030, (US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2018-2030, (US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2018–2030, (US$ Bn)
    - Brazil
    - Mexico
    - Argentina
    - Rest of Latin America
- Europe
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Drug type, 2018-2030, (US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2018-2030, (US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2018–2030, (US$ Bn)
    - U.K.
    - Germany
    - Italy
    - France
    - Spain
    - Russia
    - Rest of Europe
- Asia Pacific
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Drug type, 2018-2030, (US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2018-2030, (US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2018–2030, (US$ Bn)
    - China
    - India
    - Japan
    - ASEAN
    - Australia
    - South Korea
    - Rest of Asia Pacific
- Middle East
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Drug type, 2018-2030, (US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2018-2030, (US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2018–2030, (US$ Bn)
    - GCC
    - Israel
    - Rest of Middle East
- Africa
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Drug type, 2018-2030, (US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2018-2030, (US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2018–2030, (US$ Bn)
    - North Africa
    - Central Africa
    - South Africa
Competitive Landscape
- AstraZeneca
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Novartis AG
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- GSP plc
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Merck & Co., Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Verona Pharma plc
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Regeneron Pharmaceuticals Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Boehringer Ingelheim International GmbH
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
Section
- ReCAsearch Methodology
- About Us

*Browse 34 market data tables and 29 figures on “Asthma and COPD Market”- Global forecast to 2030

View Our Licence Options

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
Customize Now
Want to Buy a Report but have a Limited Budget?

We help clients to procure the report or sections of the report at their budgeted price. Kindly click on the below to avail
Request Discount